Connect with us


Defining the Isle of Man’s future cannabinoid regulatory structure



Listen to this article

The Isle of Man’s Department for Enterprise is seeking feedback from industry, inward investors and other interested stakeholders on its cannabinoid regulatory structure proposals with a deadline of 19 November for submissions.

In October last year, The Centre for Medicinal Cannabis (CMC) was engaged by the Isle of Man government to advise it concerning the establishment of a cannabinoid regulatory structure to support the Island’s future medicinal cannabinoid industry.

After meeting with the CMC’s medicinal cannabis experts in June 2019 at an event held in Somerset House in London, the CMC was engaged to lead on preparing a strategic vision which was subsequently presented to the Island’s Council of Ministers (the Parliamentary Cabinet) on in February.

This resulted in the successful adoption of the CMC’s proposal. The Island’s Department for Enterprise worked up these proposals into a consultation document focusing on the Regulatory framework for cannabis-derived products for export. The CMC is now encouraging its members and other interested parties to review and provide comments before 19th November.

“The Centre for Medicinal Cannabis is delighted to have been able to have worked with the Isle of Man’s Government on this important project,” says Dr Andy Yates, CMC pharmacy lead.

“I would like to see as many of our members and followers with a potential interest in the Isle of Man take some time to review the proposal and provide feedback to help promote long-term support and fostering of relationships with cannabinoid market participants”

Submissions deadline is 19 November 2020. More details are available here.